Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Teerenstra

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Journal of Clinical Epidemiology|September 12, 2013
The stepped wedge cluster randomized trial always requires fewer clusters but not always fewer measurements, that is, participants than a parallel cluster randomized trial in a cross-sectional design. In replyEsther de Hoop, Willem Woertman, Steven Teerenstra
Journal of Clinical Epidemiology|January 8, 2008
Objective and perspective determine the choice of composite endpointGeorge F Borm, Steven Teerenstra, Gerhard A Zielhuis
Statistics in Medicine|June 29, 2016
Sample size calculation for stepped wedge and other longitudinal cluster randomised trialsRichard Hooper, Steven Teerenstra, Esther de Hoop, et al.
Statistics in Medicine|June 22, 2023
Sample size for partially nested designs and other nested or crossed designs with a continuous outcome when adjusted for baselineSteven Teerenstra, Jessica Kasza, Ruslan Leontjevas, et al.
Journal of Clinical Epidemiology|June 25, 2010
A simple method for calculating power based on a prior trialGeorge F Borm, Bastiaan R Bloem, Marten Munneke, et al.
European Journal of Clinical Pharmacology|June 12, 2015
Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicinesYang Yu, Steven Teerenstra, Cees Neef, et al.
British Journal of Clinical Pharmacology|November 18, 2015
A comparison of the intrasubject variation in drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trialsYang Yu, Steven Teerenstra, Cees Neef, et al.
Clinical Trials (London, England)|March 5, 2016
Substantial risks associated with few clusters in cluster randomized and stepped wedge designsMonica Taljaard, Steven Teerenstra, Noah M Ivers, et al.
BMC Medical Research Methodology|August 26, 2016
A computational approach to compare regression modelling strategies in prediction researchRomin Pajouheshnia, Wiebe R Pestman, Steven Teerenstra, et al.
Statistical Methods in Medical Research|January 23, 2014
Level of evidence for promising subgroup findings in an overall non-significant trialJulien Tanniou, Ingeborg van der Tweel, Steven Teerenstra, et al.
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Journal of Clinical Epidemiology|September 12, 2013
The stepped wedge cluster randomized trial always requires fewer clusters but not always fewer measurements, that is, participants than a parallel cluster randomized trial in a cross-sectional design. In replyEsther de Hoop, Willem Woertman, Steven Teerenstra
Journal of Clinical Epidemiology|January 8, 2008
Objective and perspective determine the choice of composite endpointGeorge F Borm, Steven Teerenstra, Gerhard A Zielhuis
Statistics in Medicine|June 29, 2016
Sample size calculation for stepped wedge and other longitudinal cluster randomised trialsRichard Hooper, Steven Teerenstra, Esther de Hoop, et al.
Statistics in Medicine|June 22, 2023
Sample size for partially nested designs and other nested or crossed designs with a continuous outcome when adjusted for baselineSteven Teerenstra, Jessica Kasza, Ruslan Leontjevas, et al.
Journal of Clinical Epidemiology|June 25, 2010
A simple method for calculating power based on a prior trialGeorge F Borm, Bastiaan R Bloem, Marten Munneke, et al.
European Journal of Clinical Pharmacology|June 12, 2015
Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicinesYang Yu, Steven Teerenstra, Cees Neef, et al.
British Journal of Clinical Pharmacology|November 18, 2015
A comparison of the intrasubject variation in drug exposure between generic and brand-name drugs: a retrospective analysis of replicate design trialsYang Yu, Steven Teerenstra, Cees Neef, et al.
Clinical Trials (London, England)|March 5, 2016
Substantial risks associated with few clusters in cluster randomized and stepped wedge designsMonica Taljaard, Steven Teerenstra, Noah M Ivers, et al.
BMC Medical Research Methodology|August 26, 2016
A computational approach to compare regression modelling strategies in prediction researchRomin Pajouheshnia, Wiebe R Pestman, Steven Teerenstra, et al.
Statistical Methods in Medical Research|January 23, 2014
Level of evidence for promising subgroup findings in an overall non-significant trialJulien Tanniou, Ingeborg van der Tweel, Steven Teerenstra, et al.
Pageof 15